| Q38111420 | 1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. |
| Q35681702 | Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas |
| Q38835090 | Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress |
| Q36014649 | Barrett's Esophagus: Emerging Knowledge and Management Strategies |
| Q41379466 | Barrett's Oesophagus in an Achalasia Patient: Immunological Analysis and Comparison with a Group of Achalasia Patients |
| Q38363283 | Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny. |
| Q34375216 | Barrett's oesophagus: epidemiology, cancer risk and implications for management |
| Q37809363 | Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia |
| Q38151814 | Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma |
| Q38904116 | Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin |
| Q82639445 | Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus |
| Q81753352 | Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma |
| Q57111080 | Emerging Therapies in the Management of Advanced-Stage Gastric Cancer |
| Q36132761 | Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma |
| Q33605428 | Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus |
| Q54426864 | Expression of C1q complement component in Barrett's esophagus and esophageal adenocarcinoma. |
| Q83821358 | Expression of IFN-γ and IL-4 in the esophageal mucosa of patients with reflux esophagitis and Barrett's esophagus and their relationship with endoscopic and histologic grading |
| Q92887464 | Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue |
| Q53064515 | IL-4 induces columnar-like differentiation of esophageal squamous epithelium through JAK/PI3K pathway: possible role in pathogenesis of Barrett's esophagus. |
| Q38261210 | Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia |
| Q42913753 | Immune and Inflammatory Responses in GERD and Lansoprazole |
| Q37031995 | Immunologic function of dendritic cells in esophageal cancer |
| Q33840598 | Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. |
| Q58886193 | Intake of Dietary One-Carbon Metabolism-Related B Vitamins and the Risk of Esophageal Cancer: A Dose-Response Meta-Analysis |
| Q54225565 | Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus. |
| Q46555426 | Mast cell-mediated long-lasting increases in excitability of vagal C fibers in guinea pig esophagus |
| Q53275843 | NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma. |
| Q46115635 | Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study |
| Q64090145 | Predictors of dysplastic and neoplastic progression of Barrett’s esophagus |
| Q35599452 | Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model |
| Q54372521 | Role of Th-2 cytokines in the development of Barrett's esophagus in rats. |
| Q34624586 | Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions |
| Q52669411 | Serotonin disrupts esophageal mucosal integrity: an investigation using a stratified squamous epithelial model. |
| Q35234836 | Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and Barrett's esophagus are characterized by a non-inflammatory phenotype |
| Q58003551 | The contribution of intraepithelial inflammatory cells to the histological diagnosis of microscopic esophagitis |
| Q34235047 | The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue |
| Q28069924 | The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1 |
| Q54586486 | Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures. |
| Q26998011 | Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence |